4
Changes in Ownership
Cocrystal Pharma, Inc. Filed Acc 0001493152-23-025084
Options or other derivatives
- Co-CEO and CFO acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Martin James Joseph · Co-CEO and CFO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-07-18 | Grant or award : show line 1 in the form Stock Options (Right to Buy) | +30,000 | 30,000 | D |
Loading xslF345X05/ownership.xml…